(S)-2-(5-Amino-2-(((benzyloxy)carbonyl)amino)-5-oxopentanamido)acetic acid, 95.0%, 250mg

Capillaire à point de fusion, 75 mm, 1,55 mm, 1,15 mm, 1000 pièce(s)

Ethyl 7-chloro-4-hydroxy-8-methylquinoline-3-carboxylate, 95.0%, 250mg

7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinoxalin-2(1H)-one, 97%, 100mg

1-CYCLOPENTYL-1H-PYRAZOL-4-AMINE HCL, 95.0%, 250mg

3-Bromobicyclo[1.1.1]pentane-1-carboxylic acid, 98%, 500mg

3-méthyl-1,5-pentanediol, 1 l

(3,5-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 98%, 250mg

3-Morpholin-4-ylbenzonitrile, 97.0%, 25g

1-Bromo-4-chlorobutane, 99.00%, 1g

Pipettes graduées type 3, classe AS Petit emballage, 1 ml, Graduation, 0,01 ml, Extrémité avec bouchon en coton, non, 6 pièces

2-(2-piperidinyl)acetamide hydrochloride, 95.0%, 10g

7-Methoxy-3,3-dimethyl-2,3-dihydro-1H-inden-1-one, 95.0%, 1g